蹭“脑机接口”热点表述不一,IVD厂商亚辉龙遭监管警示

Core Viewpoint - The company Yahui Long (688575.SH) received a regulatory warning from the Shanghai Stock Exchange due to inaccurate and incomplete information disclosed regarding its strategic cooperation with Shenzhen Brain Machine Star Chain Technology Co., Ltd. in the "brain-computer interface" sector [2][3]. Group 1: Announcement and Market Reaction - Yahui Long announced a strategic cooperation framework agreement with Brain Machine Star Chain, which focuses on both non-invasive and invasive technologies in the brain-computer interface field [6]. - Following the announcement, Yahui Long's stock price rose by 6.52% on January 6, with trading volume increasing by 299% compared to the previous trading day [2][4]. - However, after the stock price surge, it experienced a decline, dropping by 1.08% by January 9 [4]. Group 2: Regulatory Concerns - The Shanghai Stock Exchange raised concerns about inconsistencies in Yahui Long's statements regarding the technical pathways of Brain Machine Star Chain, particularly whether they included invasive technology [3][9]. - The exchange criticized Yahui Long for not adequately disclosing risks related to the feasibility and uncertainty of the cooperation, leading to the regulatory warning [3][9]. Group 3: Product Development and Financial Performance - Yahui Long clarified that Brain Machine Star Chain's current research products are focused on non-invasive technology and that there is no invasive technology development at this time [8]. - The company reported a significant decline in revenue and net profit over the past two years, with revenues of 20.53 billion and 20.12 billion, representing year-on-year decreases of 48.42% and 2.02%, respectively [11]. - In the first three quarters of 2025, Yahui Long's revenue was 12.87 billion, down 7.69% year-on-year, and net profit was 0.60 billion, down 72.36% year-on-year [12].

Shenzhen YHLO Biotech -蹭“脑机接口”热点表述不一,IVD厂商亚辉龙遭监管警示 - Reportify